Free Account Opening + AMC Free Demat
Loading...

Rossari Biotech IPO vs UTI AMC IPO

Comparision between Rossari Biotech IPO and UTI AMC IPO.

IPO Details

Rossari Biotech IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while UTI AMC IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Rossari Biotech IPO is up to ₹496.49 Cr whereas the issue size of the UTI AMC IPO is up to ₹2,159.88 Cr. The final issue price of Rossari Biotech IPO is ₹425.00 per share and of UTI AMC IPO is ₹554.00 per share.

  Rossari Biotech IPO UTI AMC IPO
Face Value ₹2 per share ₹10 per share
Issue Price (Lower) ₹423.00 per share ₹552.00 per share
Issue Price (Upper) ₹425.00 per share ₹554.00 per share
Issue Price (Final) ₹425.00 per share ₹554.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 35 shares 27 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹50.00 Cr
OFS Issue Size 1,05,00,000 shares
OFS Issue Size (Amount)
Issue Size Total 1,16,82,033 shares 3,89,87,081 shares
Issue Size Total (Amount) up to ₹496.49 Cr up to ₹2,159.88 Cr

IPO Timetable

Rossari Biotech IPO opens on Jul 13, 2020, while UTI AMC IPO opens on Sep 29, 2020. The closing date of Rossari Biotech IPO and UTI AMC IPO is Jul 15, 2020, and Oct 01, 2020, respectively.

  Rossari Biotech IPO UTI AMC IPO
Anchor Bid Date
Issue Open Jul 13, 2020 Sep 29, 2020
Issue Close Jul 15, 2020 Oct 01, 2020
Basis Of Allotment (Tentative) Jul 20, 2020 Oct 07, 2020
Initiation of Refunds (Tentative) Jul 21, 2020 Oct 08, 2020
Credit of Share (Tentative) Jul 22, 2020 Oct 09, 2020
Listing date (Tentative) Jul 23, 2020 Oct 12, 2020
Anchor Lockin End date 1 Aug 19, 2020 Nov 06, 2020
Anchor Lockin End date 2 Oct 18, 2020 Jan 05, 2021

Financials

Rossari Biotech IPO P/E ratio is 33.81, as compared to UTI AMC IPO P/E ratio of .

  Rossari Biotech IPO UTI AMC IPO
Financial
Summary of financial Information (Restated)
Particulars For the year/period ended (Rs in Million)
31-Mar-20 31-Mar-19 31-Mar-18 31-Mar-17
Total Assets 4,715.15 2489.45 1649.50 1308.94
Total Revenue 6,038.18 5171.24 3004.29 2605.97
Profit After Tax 652.53 456.83 254.03 142.85
Summary of financial Information (Restated)
Particulars For the year/period ended (Rs in Million)
30-June-20 31-Mar-20 31-Mar-19 31-Mar-18
Total Assets 32,634.28 31,549.18 30,132.63 29,192.52
Total Revenue 2,710.68 8,909.61 10,808.94 11,627.47
Profit After Tax 1,010.75 2,764.85 3,479.27 4,050.91
Promoter Shareholding (Pre-Issue) 95.06% 98.96%
Promoter Shareholding (Post-Issue) 73%
P/E Ratio 33.81
Market Cap ₹2207.00 Cr.
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Rossari Biotech IPO retail investors (RII) are offered 40,86,765 shares while in UTI AMC IPO retail investors are offered 40,86,765 shares. Qualified institutional buyers (QIB) are offered 23,35,294 shares in Rossari Biotech IPO and in UTI AMC IPO.

  Rossari Biotech IPO UTI AMC IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 23,35,294 shares
NII 17,51,471 shares
RII 40,86,765 shares
Employee 0 shares 2,00,000 shares
Others
Total 81,73,530 shares 3,87,87,081 shares

Bids Received (Subscription)

Rossari Biotech IPO subscribed 79.37x in total, whereas UTI AMC IPO subscribed 2.31x.

  Rossari Biotech IPO UTI AMC IPO
QIB (times) 85.26x 3.34x
NII (times) 239.83x 0.93x
Big NII (times)
Small NII (times)
RII (times) 7.23x 2.32x
Employee (times) 1.34x
Other (times)
Total (times) 79.37x 2.31x

Comments

Add a public comment...